NasdaqGM - Delayed Quote USD

Invesco Nasdaq Biotechnology ETF (IBBQ)

24.24 +0.27 (+1.13%)
At close: 4:00 PM EDT
Loading Chart for IBBQ
DELL
  • Previous Close 23.97
  • Open 24.12
  • Bid 24.14 x 100
  • Ask 24.24 x 2500
  • Day's Range 24.12 - 24.26
  • 52 Week Range 18.18 - 24.84
  • Volume 3,265
  • Avg. Volume 30,536
  • Net Assets 37.2M
  • NAV 23.98
  • PE Ratio (TTM) 19.36
  • Yield 0.99%
  • YTD Daily Total Return 10.37%
  • Beta (5Y Monthly) 0.71
  • Expense Ratio (net) 0.19%

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Invesco

Fund Family

Health

Fund Category

37.2M

Net Assets

2021-06-09

Inception Date

Performance Overview: IBBQ

View More

Trailing returns as of 10/15/2024. Category is Health.

YTD Return

IBBQ
10.37%
Category
10.57%
 

1-Year Return

IBBQ
22.89%
Category
21.36%
 

3-Year Return

IBBQ
0.25%
Category
0.43%
 

People Also Watch

Holdings: IBBQ

View More

Top 10 Holdings (48.76% of Total Assets)

SymbolCompany% Assets
GILD
Gilead Sciences, Inc. 8.70%
AMGN
Amgen Inc. 7.91%
VRTX
Vertex Pharmaceuticals Incorporated 7.69%
REGN
Regeneron Pharmaceuticals, Inc. 7.27%
AZN
AstraZeneca PLC 4.51%
ALNY
Alnylam Pharmaceuticals, Inc. 3.51%
BIIB
Biogen Inc. 2.81%
MRNA
Moderna, Inc. 2.55%
ILMN
Illumina, Inc. 2.07%
ARGX
argenx SE 1.73%

Sector Weightings

SectorIBBQ
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Related ETF News

View More

Research Reports: IBBQ

View More
  • Back on October 9, we started to talk about Information Technology waking up

    Back on October 9, we started to talk about Information Technology waking up after three months of technical basing by some in the sector. We wrote the following. 'Technology was led by a few major semiconductors, including NVDA (+4%) and AVGO (+3%). NVDA has been tracing out a bullish continuous inverse head-and-shoulders, while AVGO has been forming a complex double bottom since the middle of June. Both are very close to completing these patterns and possibly breaking out to all-time highs. One concern about jumping back on the semi train is that we are not seeing other stocks completing bases and many are nowhere near highs. That can be rectified, but the strongest industry moves occur when the majority of stocks are participating.' Little did we know how prophetic those last two sentences were and in no way did we expect the obliteration that some of the semis got on October 15. ASML was destroyed, plunging over 16% after providing disappointing 2025 guidance. It was the company's worst day since the pandemic and, prior to that, during the IT wreck in 2002. KLAC plummeted 15%, and LRCX and AMAT both plunged 11%. Volume was huge and it almost felt like a capitulatory selloff. But those usually come after an extended selloff. Because the three largest semis held in there (NVDA, TSM, AVGO), losing only between 2.6% and 4.5%, the major semi ETFs (SOXX, SMH) fell only around 5%. While the major indices lost between 0.7% and 1.4%, NYSE breadth was only slightly negative at -157, this as the selling was concentrated in Information Technology, Energy, Healthcare, and Industrials. In addition, NYSE advancing volume/declining volume was neutral at 50%.

     
  • ASML: Weak 2025 Guidance Weighs on Shares, We Cut Fair Value Estimate; Shares Undervalued

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     
  • ASML: Weak 2025 Guidance Weighs on Shares, We Cut Fair Value Estimate; Shares Undervalued

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     
  • Every Cloud Has a Silver Lining; We Recommend Investors Buy Shares of ASML and Besi

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     

Related Tickers